glp 1 and sglt2 Cardiorenal Protection: Potential of Inhibitors GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes | Diabetes Therapy APhA 2025: GLP-1 Receptor Agonists

Oxidized low-density lipoprotein activates migration and degranulation of human granulocytes

Cysteine-rich dietary isothiocyanates also attenuate nuclear factor kappa B (NF-B) signaling and inflammasome activation, thereby lowering chronic inflammation that accelerates biological aging

This has profound downstream effects, including boosting cellular metabolism, promoting fat breakdown (lipolysis), and reducing the accumulation of adipose tissue in preclinical models

Studies in rodents showed, for example, that GIPR agonism mediates weight-independent insulin sensitization by improving glucose disposal into white adipose tissue (WAT)